期刊文献+

结核分枝杆菌(MTB)异质性耐药研究进展 被引量:20

Research advances in hetero-resistance of Mycobacterium tuberculosis(MTB)
下载PDF
导出
摘要 异质性耐药,是指在同一样本中同时存在耐药菌和敏感菌的现象,这体现了细菌群体从部分耐药向完全耐药转变的过程。研究异质性耐药对于认识耐药结核病的发展过程,以及评估治疗方案和指导临床用药具有重要的意义。本文对结核分枝杆菌(Mycobacterium tuberculosis,MTB)异质性耐药的产生及其对临床的影响进行了综述。 Hetero-resistance is the coexistence of both sensitive and resistant bacteria in the same specimen, which indicates the transition from partially resistant to fully resistant bacterium population. Studying hetero-resistance is of great significance in understanding the genesis of drug-resistant tuberculosis, accessing the treatment schedule, and guiding the prescription of drugs. In this article, we summarized recent progresses on hereto-resistance of Mycobacterium tuberculosis (MTB).
出处 《复旦学报(医学版)》 CAS CSCD 北大核心 2013年第1期1-4,共4页 Fudan University Journal of Medical Sciences
关键词 结核分枝杆菌(MTB) 异质性耐药 耐药结核病 Mycobacterium tuberculosis (MTB) hetero-resistance drug-resistant tuberculosis
  • 相关文献

参考文献33

  • 1Mitchison DA. The diagnosis and therapy of tuberculosisduring the past 100 years [J]. Am J Respir Crit CareMec/,2005 ,171(7) :699 - 706.
  • 2World Health Organization. Global Tuberculosis Report2012 [M]. World Health Organization,2012 : 1 ~ 2.
  • 3Telenti A, Imboden P,Marchesi F, et al. Detection ofrifampicin-resistance mutations in Mycobacteriumtuberculosis [J], Lancet ,1993,341 (8846) :647 - 650.
  • 4Zhang Y,Heym B, Allen B^et al. The catalase-peroxidasegene and isoniazid resistance of Mycobacteriumtuberculosis [J]. Nature, 1992 ,358(6387) :591 ~ 593.
  • 5Rinder H,Mieskes KT, Loscher T. Heteroresistance inMycobacterium tuberculosis [J]. Int J Tuberc Lung Dis ,2001,5(4):339 - 345.
  • 6David HL. Probability distribution of drug-resistantmutants in unselected populations of Mycobacteriumtuberculosis [J]. Appl Microbiol,197(1,20(5) :810 — 814.
  • 7Canetti G, Fox W, Khomenko A, et al. Advances intechniques of testing mycobacterial drug sensitivity, andthe use of sensitivity tests in tuberculosis controlprogrammes [J]. Bull World Health Organ,1969 ,41 (1):21 -43.
  • 8World Health Organization. Guidelines for drugsusceptibility testing for second-line anti-tuberculosisdrugs for dots-plus [ M]. World Health Organization,2001 :l-3.
  • 9Nikolayevskyy V, Balabanova Y,Simak T,et al.Performance of the Genotype MTBDRPlus assay in thediagnosis of tuberculosis and drug resistance in Samara,Russian Federation [J]. BMC Clin Pathol ,2009 ,9 :2.
  • 10Tolani MP, D; Souza DT, Mistry NF. Drug resistancemutations and heteroresistance detected using theGenoType MTBDRplus assay and their implication fortreatment outcomes in patients from Mumbai, India [J].BMC Infect Dis ,2012 ,12 :9.

同被引文献155

引证文献20

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部